Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7310 p150
31 July 2004

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Shipman inquiry
· Broad spectrum
· Public health
· Violence in pharmacies
· Pharmacy education
· Tablet identification
· Natural therapies
· Nasal sprays
· Dispensing
· The profession
· The Council
· The Society


Letters to the Editor

Nasal sprays

What is the dose of nasal pump spray?

From Mr S. Lyftingsmo

Nasal pump spray decongestants in Norway have different pump mechanisms. They deliver at least three different dose volumes and vary even within brands. For one international brand of xylometazoline spray the children’s strength is half the concentration of the adult strength but the pump stroke gives only one quarter.

This made me look at the situation in several countries. Twenty-eight bottles from five countries (Australia, Norway, Denmark, Germany and the UK) were collected (nasal decongestant, no combination products, only pump spray, no squeeze bottles). A table of the bottles can be found at www.lyftingsmo.no under “labelling”.

None of the bottles had an amount per dose indicated as part of the product name. For one of the UK bottles the number of doses in the bottle was indicated in the patient information leaflet, so the amount per dose could be calculated. For 11 of the bottles (including the remaining two from the UK) it was not possible to find out how much active ingredient there was in one pump stroke.

The patient information leaflet of one of the UK bottles contains the following text: “Important information about some of the ingredients in this product. Each 5ml product contains 1.4%w/v sorbitol, which may cause upset and diarrhoea when taken in large doses.” Such fuss about 210mg total content of sorbitol in the bottle makes it difficult for patients to find the more important and relevant information about the product.

EU directive 2001/83 is not clear on the question of strength. It says: “The name of the medicinal product followed by the common name where the product contains only one active substance and if its name is an invented name; where a medicinal product is available in several pharmaceutical forms and/or several strengths, the pharmaceutical form and/or the strength (baby, child or adult as appropriate) must be included in the name of the medicinal product.” I am sure this obscure language is no hindrance for manufacturers who wish to express strength in a clear way.

Strength indicated as concentration is a throwback from the times when bottles and droppers were used but there is no reason for us today to accept strength indications that are both insufficient and misleading. There is no doubt in my mind that the nasal pump spray is what Americans call a “metered dose” product. And one dose can be nothing else than one pump stroke. It should not only be possible, it should be easy to find out how large the dose is of the medicine you are taking.

Stein Lyftingsmo
Hospital Pharmacy of Elverum
Norway

Send your letter to The Editor

Previous Topic (Natural therapies)
Next Topic (Dispensing)

Back to Top


©The Pharmaceutical Journal